Related Experiment Video

Updated: Aug 7, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

[Comparative study of warfarin and aspirin for stroke prevention in elderly patients with atrial fibrillation]

Wei Han1, Dan-tong Shen, Yu-mei Wang

  • 1Guangzhou General Hospital of Guangzhou Command, Guangzhou 510010, China.

Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|June 24, 2006
PubMed

Insights

Warfarin is more effective than aspirin for preventing strokes in elderly patients with atrial fibrillation (AF). However, warfarin use is low, with inadequate monitoring, despite its benefits.

Area of Science:

  • Cardiology
  • Geriatrics
  • Pharmacology

Background:

  • Atrial fibrillation (AF) is a common arrhythmia in the elderly, increasing stroke risk.
  • Effective stroke prevention is crucial for this demographic.
  • Current prevention strategies require ongoing evaluation.

Purpose of the Study:

  • To analyze stroke prevention strategies in elderly patients diagnosed with atrial fibrillation.
  • To compare the efficacy and safety of warfarin versus aspirin for stroke prevention in this population.

Main Methods:

  • Retrospective analysis of clinical records from elderly AF patients over 5 years.
  • Assessment of high-risk factors across different age groups.
  • Comparison of stroke incidence and hemorrhage complications between warfarin and aspirin therapy.

Main Results:

  • Patients over 75 experienced increased complications compared to those aged 65-75.
  • Warfarin was used in 19.0% and aspirin in 73.4% of patients.
  • Warfarin significantly reduced stroke incidence but increased non-fatal hemorrhage compared to aspirin.

Conclusions:

  • Warfarin demonstrates superior efficacy over aspirin for stroke prevention in elderly AF patients.
  • Clinical use of warfarin remains low, accompanied by insufficient patient monitoring.
  • Optimizing warfarin therapy could improve stroke prevention outcomes in this vulnerable group.
Abstract

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...